Microsatellite Instability
Also known as: DNA mismatch repair protein gene mutation
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB09035 | Nivolumab | Programmed cell death protein 1 | target |
| DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00041 | Aldesleukin | 1 | Completed | 1 |
| DB11595 | Atezolizumab | 1 | Completed | 1 |
| DB00531 | Cyclophosphamide | 1 | Completed | 1 |
| DB01073 | Fludarabine | 1 | Completed | 1 |
| DB16417 | Geptanolimab | 1 | Completed | 1 |
| DB09035 | Nivolumab | 1 | Completed | 1 |
| DB09037 | Pembrolizumab | 1 | Completed | 1 |
| DB11595 | Atezolizumab | 2 | Active Not Recruiting | 1 |
| DB11945 | Avelumab | 2 | Active Not Recruiting | 1 |
| DB17465 | CD-16 NK-92 cells | 2 | Active Not Recruiting | 1 |
| DB00531 | Cyclophosphamide | 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Active Not Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Recruiting | 1 |
| DB11714 | Durvalumab | 2 | Withdrawn | 1 |
| DB01073 | Fludarabine | 2 | Recruiting | 1 |
| DB16479 | Inbakicept | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Completed | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 2 |
| DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |
| DB11771 | Tremelimumab | 2 | Recruiting | 1 |
| DB11945 | Avelumab | 3 | Terminated | 1 |